SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress DocuSign Q1 2026 Earnings EPS Beats Estimates Amid Focus on Operational Efficiency GSL Q1 2026 Earnings EPS Surpasses Estimates by 314 Amid Market Volatility Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline EICC Q4 2025 Earnings Marginal EPS Miss Amid Stable Preferred Stock Performance Atlanta Braves Holdings Inc Series C BATRK Q1 2026 Earnings EPS Beat Estimates Despite Negative Quarter